Literature DB >> 2427071

Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor.

M A Soos, K Siddle, M D Baron, J M Heward, J P Luzio, J Bellatin, E S Lennox.   

Abstract

Monoclonal antibodies for the human insulin receptor were produced following immunization of mice with IM-9 lymphocytes and/or purified placental receptor. Four separate fusions yielded 28 antibodies, all of which reacted with receptor from human placenta, liver and IM-9 cells. Some antibodies cross-reacted to varying degrees with receptor from rabbit, cow, pig and sheep, but none reacted with rat receptor. At least 10 distinct epitopes were recognized as indicated by species specificity and binding competition experiments. All of these epitopes appeared to be on extracellular domains of the receptor as shown by binding of antibodies to intact cells. In some cases the epitopes were further localized to alpha or beta subunits by immunoblotting. Several antibodies inhibited binding of 125I-insulin to the receptor, some had no effect on binding, and others enhanced the binding of 125I-insulin. It is concluded that these antibodies will be valuable probes of receptor structure and function.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2427071      PMCID: PMC1146668          DOI: 10.1042/bj2350199

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

Authors:  C R Kahn; K Baird; J S Filier; D B Jarrett
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Photoreactive insulin analogues used to characterise the insulin receptor.

Authors:  M H Wisher; M D Baron; R H Jones; P H Sönksen
Journal:  Biochem Biophys Res Commun       Date:  1980-01-29       Impact factor: 3.575

3.  Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.

Authors:  S Linde; B Hansen; O Sonne; J J Holst; J Gliemann
Journal:  Diabetes       Date:  1981-01       Impact factor: 9.461

4.  Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons.

Authors:  P F Pilch; M P Czech
Journal:  J Biol Chem       Date:  1979-05-10       Impact factor: 5.157

5.  Purification of the insulin receptor from human placenta by chromatography on immobilized wheat germ lectin and receptor antibody.

Authors:  L C Harrison; A Itin
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

6.  The subunit structure of rat liver insulin receptor. Antibodies directed against the insulin-binding subunit.

Authors:  S Jacobs; E Hazum; P Cuatrecasas
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

7.  Labeled antibodies and their use in the immunoradiometric assay.

Authors:  C N Hales; J S Woodhead
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

Review 8.  The nature and regulation of the insulin receptor: structure and function.

Authors:  M P Czech
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

9.  Hormone binding alters the conformation of the insulin receptor.

Authors:  P F Pilch; M P Czech
Journal:  Science       Date:  1980-12-05       Impact factor: 47.728

10.  Interactions between insulins and liver membrane receptors of guinea pig, calf and chicken. Exclusion of a species-specific insulin receptor.

Authors:  W Kemmler; R Renner; A Zynamon; K D Hepp
Journal:  Biochim Biophys Acta       Date:  1978-10-18
View more
  69 in total

1.  Mutational analysis of the N-linked glycosylation sites of the human insulin receptor.

Authors:  T C Elleman; M J Frenkel; P A Hoyne; N M McKern; L Cosgrove; D R Hewish; K M Jachno; J D Bentley; S E Sankovich; C W Ward
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

Review 2.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

3.  An insulin receptor in microorganisms: fact or fiction?

Authors:  E Dietz; G Uhlenbruck; R Lütticken
Journal:  Naturwissenschaften       Date:  1989-06

Review 4.  Insulin receptor (IR) and insulin-like growth factor receptor 1 (IGF-1R) signaling systems: novel treatment strategies for cancer.

Authors:  Pushpendra Singh; Jimi Marin Alex; Felix Bast
Journal:  Med Oncol       Date:  2013-12-14       Impact factor: 3.064

5.  Changes in insulin-receptor structure associated with trypsin-induced activation of the receptor tyrosine kinase.

Authors:  S Clark; G Eckardt; K Siddle; L C Harrison
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

6.  Transdominant inhibition of tyrosine kinase activity in mutant insulin/insulin-like growth factor I hybrid receptors.

Authors:  J L Treadway; B D Morrison; M A Soos; K Siddle; J Olefsky; A Ullrich; D A McClain; J E Pessin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

7.  Mutagenic structure/function analysis of the cytoplasmic cysteines of the insulin receptor.

Authors:  S L Macaulay; M Polites; M J Frenkel; D R Hewish; C W Ward
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

8.  Mechanism of insulin receptor kinase inhibition in non-insulin-dependent diabetes mellitus patients. Phosphorylation of serine 1327 or threonine 1348 is unaltered.

Authors:  M Kellerer; M Coghlan; E Capp; A Mühlhöfer; G Kroder; L Mosthaf; P Galante; K Siddle; H U Häring
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Changes in insulin-receptor tyrosine, serine and threonine phosphorylation as a result of substitution of tyrosine-1162 with phenylalanine.

Authors:  J M Tavaré; M Dickens
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

10.  Phosphorylation of calmodulin on Tyr99 selectively attenuates the action of calmodulin antagonists on type-I cyclic nucleotide phosphodiesterase activity.

Authors:  M K Saville; M D Houslay
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.